+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID06416371

Study of Retinal Vessel Leakage Using Fluorescein Angiography in People with Cerebral Small Vessel Disease A Sub-study of the Mild Stroke Study 3

Led by University of Edinburgh · Updated on 2026-03-04

40

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating retinal vessel leakage in people with cerebral small vessel disease SVD, a common cause of stroke and dementia. This observational study aims to find out if leakage occurs in retinal vessels and whether its severity matches the severity of SVD in the brain. The study also explores whether retinal angiography can be a simpler, lower-cost method to study SVD compared to specialist MRI scans. The study involves a diagnostic test using fundus fluorescein angiography, which includes an intravenous injection of fluorescent dye to capture detailed images of retinal blood vessels. Participants will be recruited from the Mild Stroke Study 3 cohort and must have had contrast-enhanced MRI within the last year. Retinal imaging will complement previous brain scans and tests. Participants will undergo fluorescein angiography to assess retinal vessel leakage, with measurements taken both automatically and manually from the images. Researchers will also review previous MRI data related to blood-brain barrier breakdown, white matter changes, and other brain features linked to SVD. The study monitors safety by excluding those with severe medical conditions or allergies and requires participants to provide informed consent. The study runs until February 2029.

CONDITIONS

Brief Title

Retinal Vessel Leakage in Cerebral Small Vessel Disease

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here